NSW Proposes New Driving Reforms for Alternative Medicine Patients
Last Updated: June 4th 2026
The New South Wales Government has announced proposed reforms that could significantly change how medicinal cannabis patients are treated under the state's road laws.
If passed by Parliament, the reforms would introduce a new framework for drivers who are legally prescribed medicinal cannabis, recognising the growing number of Australians accessing cannabis-based medicines through their healthcare practitioners.
What Is Changing?
Currently in NSW, drivers can face penalties if THC is detected during roadside drug testing, regardless of whether they have a valid prescription or are experiencing impairment.
Under the proposed reforms, eligible medicinal cannabis patients would be able to register under a new scheme and may avoid penalties where THC levels fall below a prescribed threshold following laboratory analysis. The proposal would also include additional safeguards such as driver education requirements and ongoing roadside testing.
According to the NSW Government, the reforms are intended to balance road safety with the needs of patients who are lawfully prescribed medicinal cannabis products.
Why Is This Being Discussed?
Medicinal cannabis has been legally available in Australia since 2016 under regulated prescribing pathways.
Over recent years, patients, healthcare professionals, advocacy groups and policymakers have raised concerns about the difference between laws that assess driver impairment and laws that focus on the mere presence of THC. Several parliamentary inquiries and reform proposals have considered whether existing legislation remains appropriate for patients using legally prescribed medicines.
The latest NSW proposal follows recommendations from previous reviews and discussions regarding medicinal cannabis and road safety.
What Does This Mean for Patients Today?
Importantly, the proposed reforms have not yet become law.
Until any legislative changes are enacted, drivers must continue to comply with current road rules in their state or territory. Patients prescribed medicinal cannabis should discuss any questions about driving and medication use with their treating healthcare practitioner and remain aware of their legal responsibilities.
It is also important to remember that driving while impaired remains unlawful, regardless of the medication involved.
Looking Ahead
The proposed NSW reforms represent one of the most significant discussions around medicinal cannabis and driving laws seen in Australia to date. If passed, they may influence future conversations about how prescription medicines are regulated within road safety frameworks.
As legislation progresses through Parliament, Herbly will continue to monitor developments and provide updates on changes that may affect Australian patients and healthcare professionals.
